StockMarketWire.com - Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.

The Shares and AJ Bell Media evening event webinar is an opportunity for senior board directors from listed PLCs to make a presentation about their company and update existing & potential investors on their business plans for 2020 Investors will have the chance to discover investment opportunities and get to know the companies better by asking questions online after the presentations

Other companies presenting via the webinar include: ReNeuron Group - Frenkel Topping

Sponsored by: AJ Bell Youinvest

Shareholders and potential investors can register to join the webinar for free at:

https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-020321




Story provided by StockMarketWire.com